A Bad Taste in Your Mouth on Wegovy — What's Causing It and Whether It Passes

Altered or unpleasant mouth taste is a recognised, if not frequently discussed, side effect of semaglutide (Wegovy) — most often tied to nausea, belching, or acid reflux that the medicine can cause.
The sensation is typically most noticeable after starting treatment or after a dose increase, and tends to ease as the body adjusts over days to a couple of weeks.
Good hydration, staying on top of oral hygiene, and eating small protein-rich meals can help manage taste changes while the GI effects settle.
If the taste is severe, persistent well beyond a dose-increase window, or accompanied by signs of more significant GI problems, speak to your prescriber rather than stopping treatment without advice.

A strange or unpleasant taste in the mouth is a recognised side effect of Wegovy (semaglutide), reported by some people during the early weeks of treatment and often connected to the medicine's effect on the digestive system. It isn't a sign that something has gone seriously wrong, though it can be unsettling enough to make you wonder whether to push through or raise it with your prescriber. The NHS medicines page for semaglutide lists gastrointestinal symptoms as among the most common effects of treatment, and altered taste sits within that broader picture. Wegovy is a prescription-only medicine: a clinician assesses suitability before any treatment begins, and questions like this one are exactly what that clinical relationship is for.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding the taste change: causes, how long it lasts, and what actually helps

Why semaglutide might change how things taste

The connection between Wegovy and a strange taste in the mouth usually comes down to the gut, not the taste buds themselves. Semaglutide slows gastric emptying, food moves out of the stomach more slowly than usual, which is partly why appetite falls. That same slowing can produce nausea, reflux, and burping, all of which push stomach acid or partially digested food back towards the throat. Acid reaching the back of the mouth is one of the more common reasons people describe a metallic, bitter, or sour taste while on treatment.

There is also some evidence that GLP-1 receptor agonists may directly influence taste perception, given that GLP-1 receptors are present in the brain regions involved in appetite and sensory signalling. The precise mechanism in humans isn't fully mapped, but the clinical observation (that Wegovy can leave a bad taste in the mouth) is well documented enough that patients are right to look for an explanation rather than dismiss it. The effect is not a sign that the medicine is contaminated, degraded, or incorrect.

Belching is separately listed as a common side effect of semaglutide, and repeated belching can carry gastric air and fluid upward, adding to the taste problem. If nausea is also present, the combination is often what makes the taste feel most persistent and unpleasant.

When it tends to appear, and how long most people notice it

Taste changes most commonly surface in the first few days after starting Wegovy or in the days following a dose increase. This pattern mirrors the broader GI side-effect profile of the medicine: the body hasn't yet adapted to the slower gastric motility, so symptoms are more pronounced. Most people find the discomfort (taste included) eases considerably within one to two weeks at a stable dose.

The decision this page is really helping you make is: is this a normal settling-in effect worth managing, or a signal to act? For most people experiencing a mild to moderate taste change alongside some nausea, the answer is to manage it and reassess within a fortnight. If you're several weeks into a stable dose and the taste hasn't shifted, or it worsened sharply after a dose change and hasn't recovered, that's worth raising with a prescriber directly. You can also read more about other unusual taste experiences on Wegovy that people report, which sometimes helps to gauge whether your experience is typical.

A small number of people find the taste is tied to a specific food or drink that now seems off. This is slightly different, it reflects the way semaglutide can alter food preferences and palatability, which is part of how it supports appetite reduction rather than a purely unpleasant side effect.

Practical steps that can reduce the taste while your system adjusts

Hydration is the single most practical lever here. Dry mouth makes any existing taste more concentrated and harder to clear; keeping water intake steady through the day helps flush the mouth regularly. Some people find that rinsing with plain water after meals, or brushing teeth shortly after eating rather than only morning and night, helps manage the lingering sensation.

Food choices matter too. Wegovy works best alongside a reduced-calorie diet, and what you eat affects how much acid the stomach produces. Large fatty meals generate more reflux potential; smaller portions of lower-fat food, spaced across the day, tend to produce less. Protein-rich options at each meal are also worth prioritising because lean muscle matters during weight loss, and adequate protein helps preserve it, your prescriber or a dietitian can advise on proportions for your situation specifically.

Chewing gum (sugar-free) and sugar-free mints can temporarily mask a bad taste and stimulate saliva production, which in turn helps clear the mouth. Some people notice the taste is worse in the morning, likely because acid reflux is more common when lying flat; sleeping with the head slightly elevated can help if this is the pattern you recognise. For further context on the semaglutide sweet or unusual taste experiences that people report, this page covers that specific variation.

If you're comparing how this side-effect profile compares to other weight-management treatments (tirzepatide (Mounjaro) also slows gastric emptying and shares a similar GI profile) the weight-loss treatments overview sets out the options clearly. Separately, if you're thinking about the cost of staying on Wegovy long-term, the Wegovy price comparison for UK patients explains what private treatment actually costs and what to check when comparing providers.

When to speak to a prescriber, and what yellow-card reporting covers

A taste change on its own, even an unpleasant one, rarely requires urgent action. It moves into territory that warrants a prompt clinical conversation when it is accompanied by severe or persistent stomach pain, particularly pain that radiates towards the back, which can indicate pancreatitis. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but serious side effect of GLP-1 medicines; if you are also researching the risk of vision changes associated with Wegovy, that page covers what is currently understood about this side effect. The MHRA Yellow Card scheme is the right channel if you suspect a side effect that isn't already documented in the patient information leaflet, or if your experience is severe.

Patients on Wegovy are encouraged to report unexpected or bothersome side effects through Yellow Card, not only because it helps the individual but because that data shapes MHRA monitoring of the medicine at a population level. You don't need a GP to file a report, it's a direct submission by the patient or their carer.

Our clinical team at nume reviews every patient's situation before treatment begins and remains available for aftercare questions throughout. If the taste change is bothering you and you'd like a clinical opinion on whether it fits the expected settling-in pattern or needs a closer look, our prescribers are there for exactly that. You can reach the team through our contact page or by starting a new consultation, and for a broader picture of what treatment with semaglutide involves, the Wegovy overview is a good place to read first.

If you'd like a clinical assessment for Wegovy treatment, start your free consultation and a GPhC-registered prescriber will review your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions